Symbol
| ITGA8
| contributors: mct - updated : 11-03-2016
|
HGNC name
| integrin, alpha 8
|
HGNC id
| 6144
|
corresponding disease(s)
|
BRA1
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
associated with increased cardiac interstitial fibrosis | tumoral
|  
|  
| --low
|  
|
by aberrant promoter methylation in ovarian cancers (Cai 2007) | constitutional
| germinal mutation
|  
|  
|  
|
in isolated Congenital anomalies of the kidney and urinary tract (CAKUT) | |
Susceptibility
|
to hypertrophic cardiomyopathy to modification of the progression of renal failure in autosomal-dominant polycystic kidney disease (ADPK |
Variant & Polymorphism
other
| modifier gene of MYBPC3, in hypertrophic cardiomyopathy |
|
polymorphism of the ITGA8 promoter modifies the progression of renal failure in ADPKD |
|
|
Candidate gene
Marker
| ITGA2B, ITGA8, GIT1, and SHC1 were identified as independent prognostic factors of overall survival of clear cell renal cell carcinoma | Therapy target
| | |
| mice deficient for ITGA8 have structural alterations in glomeruli but not in renal arteries |